Luís F Moita1, Timothy E Sweeney2, Pedro Póvoa3,4,5. 1. Instituto Gulbenkian de Ciência, Oeiras, Portugal. 2. Inflammatix, Inc.,, Redwood City, CA, USA. 3. NOVA Medical School, New University of Lisbon, Lisbon, Portugal. pedrorpovoa@gmail.com. 4. Center for Clinical Epidemiology and Research Unit of Clinical Epidemiology, OUH Odense University Hospital, Odense, Denmark. pedrorpovoa@gmail.com. 5. Polyvalent Intensive Care Unit, Hospital de São Francisco Xavier, CHLO, Estrada Do Forte Do Alto Do Duque, 1449-005, Lisbon, Portugal. pedrorpovoa@gmail.com.
Authors: Roman A Lukaszewski; Helen E Jones; Vivian H Gersuk; Paul Russell; Andrew Simpson; David Brealey; Jonathan Walker; Matt Thomas; Tony Whitehouse; Marlies Ostermann; Alexander Koch; Kai Zacharowski; Mogens Kruhoffer; Damien Chaussabel; Mervyn Singer Journal: Intensive Care Med Date: 2022-07-13 Impact factor: 41.787
Authors: O S Garvik; P Póvoa; B Magnussen; P J Vinholt; C Pedersen; T G Jensen; H J Kolmos; A T Lassen; K O Gradel Journal: Epidemiol Infect Date: 2020-02-26 Impact factor: 2.451